Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-0.19%
-$0.29
$154.76
23:25 18/10/17
$154.76
23:25 18/10/17
DAILY VARIATION
-0.19%
-$0.29
VOLUME
1,050,458
DATA
52 Week High
n/a
52 Week Low
n/a
Shares Issued
252.12m
Market Cap
$39,017.91m
RiskGrade
n/a
Beta
n/a
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 0.6% 20.0%
ROCE 0.0%
Latest F'cast
P/E -337.1 9,183.8
PEG 0.0 -999,999.0
Pr/Revenue 23.0 17.4
Pr/Book 29.2
Latest F'cast
Revenue 64.9% -4.2%
PBT 0.0% n/a
EPS 0.0% -37.1%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 -231.00¢ -54.5 0.0 n/a n/a 0.0%
2016-12-31 1,702.18 -67.37 -46.00¢ -160.2 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 2,218.67 444.70 167.76c 9,183.8 n/a 0% 0.00c 0.0%
2018-12-31 2,712.41 810.51 312.39c 4,846.6 56.2 86% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found